Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“and is especially prevalent in North America.6,138,139”
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Self-citation(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus
Bannerman, T. L., Hancock, G. A., Tenover, F. C., & Miller, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.551-555.1995 · Cited by 550
Self-citationCharacterization of glycopeptide-resistant enterococci from U.S. hospitals
Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2311 · Cited by 395
Self-citationApplication of pulsed-field gel electrophoresis to molecular epidemiology
Maslow, J. N. (1993) · Medical Entomology and Zoology · Cited by 382
Research works printed but not linked: 7
- 1997, MMWR Morb Mortal Wkly Rep, 46, 624
- 2000, MMWR Morb Mortal Wkly Rep, 48, 1165
- 2002, MMWR Morb Mortal Wkly Rep, 51, 565
- Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:264-82.
- 2001, MMWR Morb Mortal Wkly Rep, 50, 1
- 1995, MMWR Morb Mortal Wkly Rep, 44, 1
- 1997, MMWR Morb Mortal Wkly Rep, 46, 626
Cited by
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
“aureus, with an MIC of 32–1,024 g/ml or more, have been isolated from clinical specimens, none to date have caused respiratory tract infection and all have been sensitive to linezolid (61, 62).”
BackgroundSiegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“vascular catheters, surgical wounds, indwelling prosthetic devices, hemodialysis)(6,8,9) and is especially prevalent in North America.(6,138,139) Increasing rates of oxacillin-resistant S aureus”
BackgroundThe role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
“aureus (VRSA) isolates have now been reported in the United States (142, 145, 146, 151, 286, 996).”
BackgroundMethicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Self-citationManagement of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
“aureus (VRSA) due to the acquisition of the vanA gene from vancomycinresistant enterococci were first reported from the United States in 2002 (38, 47).”
BackgroundGenetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Self-citationLevine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
“It appears that the staphylococcus acquired the VanA gene from the VRE [77, 78].”
BackgroundInfluentialAntibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
“In the last decades, the incidence of drug-resistant ente-rococcal infections increased, especially for vancomycin-resistant Enterococci (VRE) reaching 14.9% in 2017 in the European Union (EU) (ECDC, 2018b) (Fig 1B) and 30% in the United States of America (USA) (CDC, 2019).”
InfluentialMechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
“However, unlike MRSA, enterococci have been able to recruit and maintain a variety of gene clusters encoding the biochemical machinery for vancomycin resistance.”
BackgroundInfluentialPeritoneal Dialysis-Related Infections Recommendations: 2005 Update
Piraino, B., Bailie, G. R., Bernardini, J., Boeschoten, E., Gupta, A., Holmes, C., Kuijper, E. J., Li, P. K.-T., Lye, W.-C., Mujais, S., et al. (2005) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686080502500203 · Cited by 700
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Mechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 637
Self-citationBiodegradable nanostructures with selective lysis of microbial membranes
Nederberg, F., Zhang, Y., Tan, J. P. K., Xu, K., Wang, H., Yang, C., Gao, S., Guo, X. D., Fukushima, K., Li, L., et al. (2011) · Nature Chemistry · doi:10.1038/nchem.1012 · Cited by 614
IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes
Lipsky, B. A., Aragón‐Sánchez, J., Diggle, M., Embil, J., Kono, S., Lavery, L., Senneville, É., Urbančič‐Rovan, V., Van Asten, S., & on behalf of the International Working Group on the Diabetic Foot (IWGDF) (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2699 · Cited by 568
Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
Willems, R. J. L., Top, J., van Santen, M., Robinson, D. A., Coque, T. M., Baquero, F., Grundmann, H., & Bonten, M. J. M. (2005) · Emerging Infectious Diseases · doi:10.3201/1106.041204 · Cited by 558
Antimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Cong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527
“aureuswith intermediate and complete resistance to vancomycin have emerged within the past two decades [10,11], and have become a serious public health concern [12].”
BackgroundInfluentialStaphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
“aureus strains have been identified (297).”
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Citron, D. M., Goldstein, E. J. C., Merriam, C. V., Lipsky, B. A., & Abramson, M. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00551-07 · Cited by 509
“In fact, the first two isolates of vancomycin-resistant MRSA strains were from diabetic patients with foot lesions (8).”
BackgroundCrank, C., & O'Driscoll, T. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s54125 · Cited by 505
“In 2002, the threat of VRE colonization and infections increased when the first patient case of VRE transmitting vanA resistance genes to methicillin-resistant Staphylococcus aureus (MRSA) to form a vancomycin-resistant Staphylococcus aureus (VRSA) isolate was reported.(9) In fe ct io n an d D ru g R es is ta nc e do…”
Koreen, L., Ramaswamy, S. V., Graviss, E. A., Naidich, S., Musser, J. M., & Kreiswirth, B. N. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.792-799.2004 · Cited by 484
“aureus (MRSA) strains (23) and the movement of the vanA operon from Enterococcus faecalis into MRSA, establishing strains with high-level vancomycin resistance (3), further heighten the public health concerns.”
BackgroundVancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
“In June 2002, the Michigan Department of Community Health reported the first clinical case of vanA-mediated VRSA infection in the world [15, 16].”
BackgroundSelf-citationStaphylococcus aureus : superbug, super genome?
Lindsay, J. A., & Holden, M. T. G. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.06.004 · Cited by 465
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
(2017) · PubMed Central
Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus
Cheung, A. L., Bayer, A. S., Zhang, G., Gresham, H., & Xiong, Y.-Q. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00309-2 · Cited by 449
Tenover, F. C., & Moellering, R. C. (2007) · Clinical Infectious Diseases · doi:10.1086/513203 · Cited by 452
“In June 2002, the first naturally occurring vanA-containing S. aureus isolate was recovered from a patient in Michigan [20].”
BackgroundSelf-citationBactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French, G. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl393 · Cited by 441
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
Evolutionary Models of the Emergence ofMethicillin-Resistant Staphylococcusaureus
Robinson, D. A., & Enright, M. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3926-3934.2003 · Cited by 435
“aureus (MRSA) strains with resistance to vancomycin are emerging (4, 13).”
BackgroundBacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Bhalla, A., Pultz, N. J., Gries, D. M., Ray, A. J., Eckstein, E. C., Aron, D. C., & Donskey, C. J. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502369 · Cited by 418
Kang, M., Zhou, C., Wu, S., Yu, B., Zhang, Z., Song, N., Lee, M. M. S., Xu, W., Xu, F.-J., Wang, D., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b07162 · Cited by 414
Antimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Appelbaum, P. C. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01344.x · Cited by 376
“aureus (VRSA), which is even more alarming, as these isolates demonstrate complete vancomycin resistance [11–14].”
BackgroundHegstad, K., Mikalsen, T., Coque, T. M., Werner, G., & Sundsfjord, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03226.x · Cited by 359
Antibiotic Resistance Mechanisms of Clinically Important Bacteria
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., & Pavilonis, A. (2011) · Medicina · doi:10.3390/medicina47030019 · Cited by 362
Carpenter, C. F., & Chambers, H. F. (2004) · Clinical Infectious Diseases · doi:10.1086/383472 · Cited by 358
“[13] and the Pennsylvania isolate (MIC90, 0.”
Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.275-280.2004 · Cited by 370
Self-citationGottler, L. M., & Ramamoorthy, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.009 · Cited by 354
“aureus, a bacteria that has quickly developed multiple resistance to current antimicrobial compounds including methicillin and vencomycin [2–5] was included in these attempts and showed no resistance to Pexiganan [54].”
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
Vivas, R., Barbosa, A. A. T., Dolabela, S. S., & Jain, S. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0319 · Cited by 343
Evolution of antibiotic resistance at non-lethal drug concentrations
Andersson, D. I., & Hughes, D. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.005 · Cited by 339
“…emerged de novo in treated patients s a result of horizontal gene transfer of resistance genes include he appearance of vancomycin resistant MRSA (Chang et al., 2003; eigel et al., 2003) and carbapenem resistant E. coli (Richter et al., 011) where the resistant donor bacteria were either…”
BackgroundRaad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R., & Hachem, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00350-06 · Cited by 350
Shariati, A., Dadashi, M., Moghadam, M. T., van Belkum, A., Yaslianifard, S., & Darban-Sarokhalil, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-69058-z · Cited by 329
Antimicrobial Resistance in Gram-Positive Bacteria
Rice, L. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.012 · Cited by 276
Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing
Bae, T., Banger, A. K., Wallace, A., Glass, E. M., Åslund, F., Schneewind, O., & Missiakas, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404728101 · Cited by 315
A play in four acts: Staphylococcus aureus abscess formation
Cheng, A. G., DeDent, A. C., Schneewind, O., & Missiakas, D. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.01.007 · Cited by 310
Liu, C., & Chambers, H. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3040-3045.2003 · Cited by 321
“Since then, a number of cases have been reported worldwide, with eight confirmed cases in the United States as of June 2002 (9, 13).”
BackgroundEnvelope Structures of Gram-Positive Bacteria
Rajagopal, M., & Walker, S. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_5021 · Cited by 292
“aureus (VRSA) have been identified have involved coinfection with VRE (Weigel et al. 2003; Zhu et al. 2008; Sievert et al. 2008; Chang et al. 2003; Whitener et al. 2004).”
BackgroundHistory of antimicrobial drug discovery: Major classes and health impact
Aminov, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.001 · Cited by 296
Vaccine assembly from surface proteins of Staphylococcus aureus
Stranger-Jones, Y. K., Bae, T., & Schneewind, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606863103 · Cited by 309
Penicillin‐binding protein 2a of methicillin‐resistant Staphylococcus aureus
Fishovitz, J., Hermoso, J. A., Chang, M., & Mobashery, S. (2014) · IUBMB Life · doi:10.1002/iub.1289 · Cited by 279
“VC 2014 IUBMB Life, 66(8):572–577, 2014”
Antimicrobial peptides: new hope in the war against multidrug resistance
Mwangi, J., Hao, X., Lai, R., & Zhang, Z.-Y. (2019) · Zool. Res. · doi:10.24272/j.issn.2095-8137.2019.062 · Cited by 289
Emergence and management of drug-resistant enterococcal infections
Arias, C. A., & Murray, B. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.637 · Cited by 294
Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States
Kuehnert, M. J., Hill, H. A., Kupronis, B. A., Tokars, J. I., Solomon, S. L., & Jernigan, D. B. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.040831 · Cited by 287
“aureus resistance to vancomycin, the last commonly used antimicrobial drug to which this organism was considered uniformly susceptible, has emerged (5).”
BackgroundHealth Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito, N., Miró, J. M., de Lazzari, E., Cabell, C. H., del Río, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00004 · Cited by 277
Kakoullis, L., Papachristodoulou, E., Chra, P., & Panos, G. (2021) · Antibiotics · doi:10.3390/antibiotics10040415 · Cited by 235
“VRSA has acquired vanA operon from vancomycin resistant enterococci (VRE), and was first identified in diabetic patients suffering from concomitant infection by the 2 pathogens [12,13].”
BackgroundEmergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen
Top, J., Willems, R., & Bonten, M. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00383.x · Cited by 260
Industrial natural product chemistry for drug discovery and development
Bauer, A., & Brönstrup, M. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70058e · Cited by 255
Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics
Mubeen, B., Ansar, A. N., Rasool, R., Ullah, I., Imam, S. S., Alshehri, S., Ghoneim, M. M., Alzarea, S. I., Nadeem, M. S., & Kazmi, I. (2021) · Antibiotics · doi:10.3390/antibiotics10121473 · Cited by 244
Jones, R. N. (2006) · Clinical Infectious Diseases · doi:10.1086/491710 · Cited by 254
Sortase as a Target of Anti-Infective Therapy
Maresso, A. W., & Schneewind, O. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07110 · Cited by 249
Salimnia, H., Fairfax, M. R., Lephart, P. R., Schreckenberger, P., DesJarlais, S. M., Johnson, J. K., Robinson, G., Carroll, K. C., Greer, A., Morgan, M., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01679-15 · Cited by 243
“This was isolated in one of the participating laboratories and was found to have acquired vanA (32).”
BackgroundEnzymatic methods for glyco(diversification/randomization) of drugs and small molecules
Gantt, R. W., Peltier-Pain, P., & Thorson, J. S. (2011) · Natural Product Reports · doi:10.1039/c1np00045d · Cited by 243
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
Appelbaum, P. C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.011 · Cited by 248
Community‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
Cattoir, V., & Leclercq, R. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks469 · Cited by 234
Dubrac, S., & Msadek, T. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1175-1181.2004 · Cited by 228
“aureus highlights the growing threat this bacterium poses to human health and the urgent need to develop novel therapeutic approaches (5).”
BackgroundMersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., & Ljungh, Å. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh387 · Cited by 231
“Methicillin-resistant S. aureus (MRSA) have spread worldwide, with infection rates that are <5% in the Scandinavian countries but >40% in Japan, the USA and southern Europe, 1 and the first vancomycin-resistant strains have been isolated in the USA.”
BackgroundHaddad Kashani, H., Schmelcher, M., Sabzalipoor, H., Seyed Hosseini, E., & Moniri, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00071-17 · Cited by 225
“VISA was first identified from a clinical specimen in Japan in 1997 (30), while the first VRSA strain was identified 5 years later in the United States (31).”
Backgroundβ-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome
Fuda, C. C. S., Fisher, J. F., & Mobashery, S. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5148-6 · Cited by 223
Lindsay, J. A., & Holden, M. T. G. (2006) · Functional & Integrative Genomics · doi:10.1007/s10142-005-0019-7 · Cited by 221
“tions are treated with vancomycin, but the first high-level vancomycin-resistant isolates (VRSA) were recently described (Anonymous 2002a,b; Chang et al. 2003).”
BackgroundFriend Turned Foe: Evolution of Enterococcal Virulence and Antibiotic Resistance
Van Tyne, D., & Gilmore, M. S. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091213-113003 · Cited by 213
Staphylococcus aureus with Reduced Susceptibility to Vancomycin
Cosgrove, S. E., Carroll, K. C., & Perl, T. M. (2004) · Clinical Infectious Diseases · doi:10.1086/422458 · Cited by 223
Leavis, H. L., Willems, R. J. L., van Wamel, W. J. B., Schuren, F. H., Caspers, M. P. M., & Bonten, M. J. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030007 · Cited by 215
“ylococcus aureus [13–16] stressed the need to better understand molecular epidemiology, as well as transmissibility and virulence of enterococci, to control further spread and develop treatment and eradication strategies.”
BackgroundGlycopeptide Antibiotics: from Conventional Molecules to New Derivatives
Van Bambeke, F., Van Laethem, Y., Courvalin, P., & Tulkens, P. M. (2004) · Drugs · doi:10.2165/00003495-200464090-00001 · Cited by 213
Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice
Kim, H. K., Cheng, A. G., Kim, H.-Y., Missiakas, D. M., & Schneewind, O. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092514 · Cited by 203
The Threat of Antimicrobial Resistance on the Human Microbiome
Brinkac, L., Voorhies, A., Gomez, A., & Nelson, K. E. (2017) · Microbial Ecology · doi:10.1007/s00248-017-0985-z · Cited by 186
Community-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen
Saïd-Salim, B., Mathema, B., & Kreiswirth, B. N. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502231 · Cited by 198
“instances the strains contained the transposon Tnl546 harboring the vanA gene.(6) The ability of vanA to be mobi-”
BackgroundAntibiotic resistance—the problem intensifies
LEVY, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.001 · Cited by 197
Schlievert, P. M., Strandberg, K. L., Lin, Y.-C., Peterson, M. L., & Leung, D. Y. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.039 · Cited by 194
Saha, B., Singh, A. K., Ghosh, A., & Bal, M. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47144-0 · Cited by 195
“Only four vancomycin-resistant Staphylococcus aureus (VRSA) isolates have been reported so far from the USA (Chang et al., 2003; Tenover et al., 2004; CDC, 2004; Weigel et al., 2007; Perichon & Courvalin, 2006).”
BackgroundThomas, V. C., Hiromasa, Y., Harms, N., Thurlow, L., Tomich, J., & Hancock, L. E. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06703.x · Cited by 197
“contributes to biofilm development of Enterococcus faecalis”
BackgroundFeng, G., Yuan, Y., Fang, H., Zhang, R., Xing, B., Zhang, G., Zhang, D., & Liu, B. (2015) · Chemical Communications · doi:10.1039/c5cc03807c · Cited by 190
Hajighahramani, N., Nezafat, N., Eslami, M., Negahdaripour, M., Rahmatabadi, S. S., & Ghasemi, Y. (2017) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2016.12.010 · Cited by 195
“In recent years, S. aureus strains have demonstrated moderate to complete resistance to vancomycin, which is indicatedas the last line treatment (Chang et al., 2003; Weigel et al., 2003; Stranger-Jones et al., 2006).”
BackgroundVancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment
Zirakzadeh, A., & Patel, R. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.529 · Cited by 192
New strategies for novel antibiotics: peptides targeting bacterial cell membranes
Lohner, K. (2009) · General Physiology and Biophysics · doi:10.4149/gpb_2009_02_105 · Cited by 188
“strain was identified in Japan already in 1996 (Chang et al. 2003; Fluit and Schmitz 2003).”
BackgroundHe, X., Dai, L., Ye, L., Sun, X., Enoch, O., Hu, R., Zan, X., Lin, F., & Shen, J. (2022) · Advanced Science · doi:10.1002/advs.202105223 · Cited by 186
Genomic Basis for Methicillin Resistance in Staphylococcus aureus
Hiramatsu, K., Ito, T., Tsubakishita, S., Sasaki, T., Takeuchi, F., Morimoto, Y., Katayama, Y., Matsuo, M., Kuwahara-Arai, K., Hishinuma, T., et al. (2013) · Infection & Chemotherapy · doi:10.3947/ic.2013.45.2.117 · Cited by 189
Alves, D. R., Gaudion, A., Bean, J. E., Perez Esteban, P., Arnot, T. C., Harper, D. R., Kot, W., Hansen, L. H., Enright, M. C., & Jenkins, A. T. A. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01789-14 · Cited by 182
“aureus (MRSA) and isolates with decreased susceptibility to vancomycin (4).”
BackgroundMouse models for infectious diseases caused by Staphylococcus aureus
Kim, H. K., Missiakas, D., & Schneewind, O. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.04.007 · Cited by 186
Metadata
- Authors
- Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., Cardo, D., & Fridkin, S. K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Wayne State University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1342-1347
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068037991
- Semantic Scholar
- f0afb59f819a65ada63076a36807f63502c4437d
- Cited by
- 1,095
- References
- 18
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 24 · 2023: 28 · 2022: 24 · 2021: 35 · 2020: 29 · 2019: 39 · 2018: 28 · 2017: 29 · 2016: 28 · 2015: 55 · 2014: 54 · 2013: 51 · 2012: 65
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- vancomycin-resistant Staphylococcus aureus, vanA gene, vancomycin resistance, diabetes mellitus, peripheral vascular disease, foot ulcer, vancomycin-resistant Enterococcus faecalis, antibiotic resistance transfer, catheter-related infection
- MeSH terms
- Adult, Catheterization, Debridement, Female, Renal Dialysis, Humans, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Contact Tracing, Diabetic Foot, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.